Peptide Aggregation: 7 Major Causes, Detection Methods and Stability Implications
Peptide aggregation occurs when peptide molecules associate to form assemblies containing two or more molecules. These assemblies may remain soluble, develop into larger particles or eventually form visible precipitates. Their formation depends on the peptide’s sequence, molecular structure, concentration and surrounding environment.
Aggregation is an important consideration in synthetic peptide research because a preparation can retain its expected molecular mass while undergoing substantial changes in physical behaviour.
A clear solution does not necessarily contain only individual peptide molecules. Small soluble aggregates may be present without producing visible cloudiness. Conversely, a cloudy preparation does not establish the chemical identity or structure of the particles responsible.
Some peptides also form ordered assemblies, including fibrillar structures, under particular experimental conditions. These structures may be relevant to studies of molecular self-assembly, peptide materials and protein misfolding.
However, not every peptide forms amyloid-like fibrils, and not every molecular association represents irreversible instability.
Understanding peptide aggregation requires distinguishing reversible association, irreversible aggregation, precipitation and chemical degradation.
Laboratories use techniques such as size-exclusion chromatography (SEC), dynamic light scattering (DLS), analytical ultracentrifugation, spectroscopy and microscopy to investigate these behaviours.
Each method provides different information, and no single technique is universally suitable for every peptide or aggregate type.
This article examines seven major factors associated with peptide aggregation, explains how laboratories detect molecular assemblies and discusses the relationship between aggregation, solubility, storage conditions and analytical quality control.
What Is Peptide Aggregation?
Peptide aggregation describes the association of peptide molecules into larger molecular assemblies.
The interactions responsible may include hydrophobic effects, hydrogen bonding, electrostatic interactions and other intermolecular forces.
The resulting assemblies can differ considerably in size, structure and behaviour.
Monomeric Peptides
A monomer is an individual peptide molecule that is not associated with other peptide molecules in the assembly being considered.
Oligomeric Assemblies
Oligomers contain a relatively small number of associated molecules.
They may be transient, stable or part of a larger assembly pathway.
Larger Aggregates
Larger assemblies may contain many peptide molecules and exhibit complex structural characteristics.
Fibrillar Assemblies
Some peptides can form elongated structures, including fibrils.
Certain fibrils contain ordered intermolecular arrangements.
Precipitates
Precipitation occurs when material separates from a solution into a distinct solid-rich phase.
Precipitated material may contain aggregated peptides, but precipitation and aggregation are not identical concepts.
Reversible vs Irreversible Aggregation
Some assemblies can dissociate when environmental conditions change.
Others may persist because of strong intermolecular interactions or structural changes.
Whether aggregation is reversible must be established experimentally.
The term peptide aggregation therefore describes a broad range of molecular behaviours rather than one uniform process.
Why Peptide Aggregation Matters in Research
Aggregation can influence the physical characteristics and analytical interpretation of peptide preparations.
Dissolved Concentration
If molecules form insoluble aggregates, the concentration of peptide remaining in the dissolved phase may decrease.
Molecular Distribution
A preparation may contain monomers, oligomers and larger assemblies simultaneously.
Analytical Measurements
Aggregates may influence light scattering, chromatography, spectroscopy and other measurements.
Physical Stability
Aggregation can develop or change over time.
Experimental Reproducibility
Differences in aggregate populations may contribute to variation between laboratory measurements.
Material Characterisation
For some research applications, self-assembly is itself the phenomenon being studied.
For others, aggregation is an unwanted change in sample properties.
Consequently, peptide aggregation should be interpreted in the context of the actual scientific objective.
7 Major Causes and Contributing Factors of Peptide Aggregation
Aggregation often results from interactions between multiple factors rather than a single isolated cause.
1. Amino Acid Sequence and Hydrophobic Interactions
Amino acid sequence strongly influences peptide behaviour.
Different residues contribute distinct chemical properties, including polarity, charge and hydrophobicity.
Hydrophobic Residues
Hydrophobic regions may favour association between peptide molecules in aqueous environments.
This can contribute to aggregation under suitable conditions.
Sequence Arrangement
The position of hydrophobic residues matters.
Two peptides with similar amino acid compositions may behave differently because their residues are arranged differently.
Aromatic Residues
Aromatic side chains may contribute to particular intermolecular interactions.
However, their presence does not guarantee aggregation.
Secondary Structure
Some sequences favour conformations that support intermolecular association.
Sequence-Based Prediction
Computational tools may identify regions with aggregation propensity.
These predictions are not substitutes for experimental evidence.
Peptide aggregation depends on the complete sequence and its environment rather than a simple count of hydrophobic residues.
2. Peptide Concentration
Concentration influences how frequently peptide molecules encounter one another.
In some systems, higher concentration increases the likelihood of molecular association.
Molecular Encounters
As concentration increases, intermolecular encounters generally become more frequent.
Association Equilibria
Some peptides form reversible oligomers through concentration-dependent equilibria.
Nucleation
Certain aggregation processes involve the formation of an initial assembly that can support subsequent growth.
Concentration Thresholds
Some systems exhibit marked changes in behaviour above particular concentration ranges.
These thresholds depend on the peptide and conditions.
Nonlinear Behaviour
Aggregation does not necessarily increase linearly with concentration.
The kinetics may involve nucleation, growth, fragmentation or other processes.
A scientifically useful peptide aggregation study should document concentration and distinguish equilibrium behaviour from time-dependent changes.
3. Solution pH and Net Charge
pH influences the ionisation of peptide functional groups.
Changes in ionisation can alter electrostatic interactions between molecules.
Acidic and Basic Residues
Aspartic acid, glutamic acid, lysine, arginine and histidine can contribute to pH-dependent charge behaviour.
Net Charge
The overall charge of a peptide depends on the combined ionisation states of its functional groups.
Electrostatic Repulsion
Like-charged molecules may repel one another.
Reduced electrostatic repulsion can favour association in some systems.
Isoelectric Point
Near the isoelectric point, a peptide has approximately zero net charge.
Some peptides exhibit increased aggregation or reduced solubility near this region.
However, this is not a universal rule.
pH-Dependent Structural Changes
pH can also influence conformation and chemical stability.
Peptide aggregation should therefore be assessed across relevant pH conditions rather than predicted from the isoelectric point alone.
4. Temperature and Thermal Stress
Temperature can influence molecular motion, conformational behaviour and intermolecular interactions.
Molecular Mobility
Temperature affects the movement and interactions of molecules.
Conformational Changes
Some peptides may adopt different conformations under different thermal conditions.
Aggregation Kinetics
Temperature can influence the rate at which assemblies form or change.
Chemical Reactions
Thermal exposure may also accelerate certain degradation pathways.
Temperature Fluctuations
Changes in temperature can influence physical behaviour in some preparations.
Peptide-Specific Responses
Higher temperature does not universally increase aggregation, and lower temperature does not universally prevent it.
The direction of the effect depends on the peptide and formulation.
Reliable peptide aggregation conclusions require measurements under defined thermal conditions.
5. Ionic Strength and Salt Composition
Dissolved ions can influence electrostatic interactions between peptide molecules.
Charge Screening
Ions in solution can reduce the effective range of electrostatic interactions.
Salt Identity
Different ions may influence peptide behaviour differently.
Counterions
Peptide salt forms can affect the surrounding chemical environment.
Molecular Association
Changes in ionic conditions may favour or discourage aggregation depending on the system.
Solubility Effects
Salt composition can also influence equilibrium solubility.
Interpretation
Ionic strength alone does not determine aggregation behaviour.
Peptide aggregation studies should consider both salt concentration and the identities of relevant ions.
6. Solvent Composition and Formulation Environment
The surrounding solvent influences peptide interactions.
Solvent Polarity
Solvent polarity can affect the balance between peptide–solvent and peptide–peptide interactions.
Hydrogen Bonding
Hydrogen bonding may contribute to molecular association and structural organisation.
Formulation Constituents
Additional components can influence physical behaviour.
Solvent Transitions
Changes in solvent composition may alter solubility or molecular association.
Interfacial Effects
Interactions at liquid–air or liquid–solid interfaces may contribute to aggregation in certain systems.
Analytical Compatibility
Solvent composition can also affect the performance of analytical methods.
Peptide aggregation should be evaluated in the actual formulation or solvent system relevant to the research question.
7. Storage Duration, Surfaces and Environmental Exposure
Aggregation may develop over time, particularly when conditions favour molecular association.
Storage Duration
Some aggregation processes are time-dependent.
Container Surfaces
Peptides may interact with glass, polymer or other surfaces.
Air–Liquid Interfaces
Exposure to interfaces can influence some peptide systems.
Mechanical Stress
Agitation or other mechanical conditions may affect aggregation in certain formulations.
Light Exposure
Light may contribute to chemical modifications that indirectly influence physical behaviour in susceptible peptides.
Oxidation and Other Modifications
Chemical changes may alter molecular interactions and aggregation propensity.
However, aggregation can also occur without chemical degradation.
Batch and Packaging Differences
Differences in packaging or handling history may influence observed behaviour.
Peptide aggregation is therefore closely connected to the broader evaluation of storage conditions and physical stability.
Read Peptide Storage Conditions for additional background.
Summary of the Seven Aggregation Factors
| Factor | Potential influence | Important consideration |
|---|---|---|
| Amino acid sequence | Hydrophobic and structural interactions | Sequence-specific behaviour |
| Concentration | Molecular encounters and association equilibria | May be nonlinear |
| pH | Ionisation and electrostatic interactions | pI is not a universal predictor |
| Temperature | Molecular mobility and aggregation kinetics | Effects vary by system |
| Ionic strength | Charge screening and salt interactions | Salt identity matters |
| Solvent composition | Peptide–solvent and peptide–peptide interactions | Formulation-specific |
| Storage and interfaces | Time-dependent association and surface effects | Environmental history matters |
These factors may interact, making peptide aggregation difficult to predict from a single molecular characteristic.
Types of Peptide Aggregation
Not all aggregates have the same physical or structural properties.
Reversible Oligomerisation
Some peptides form small assemblies that remain in equilibrium with monomeric molecules.
The relative populations may depend on concentration and environmental conditions.
Amorphous Aggregation
Amorphous aggregates lack the long-range structural order associated with crystalline materials.
Their size and morphology can vary.
Fibrillar Aggregation
Some peptides form elongated assemblies with organised molecular arrangements.
Amyloid-Like Assemblies
Certain peptide systems can form fibrils with characteristic cross-beta structural features.
However, amyloid-like behaviour is not universal among synthetic peptides.
Insoluble Aggregates
Larger assemblies may separate from solution.
Mixed Populations
A single sample may contain multiple aggregate populations.
This diversity explains why peptide aggregation often requires more than one analytical method.
Peptide Aggregation vs Peptide Precipitation
Aggregation and precipitation are related but distinct.
| Characteristic | Aggregation | Precipitation |
|---|---|---|
| Main process | Association of molecules into assemblies | Separation of material into a distinct phase |
| Visibility | May be invisible | May produce visible particles or sediment |
| Solubility | Aggregates may remain soluble | Material separates from the dissolved phase |
| Analytical methods | SEC, DLS, spectroscopy, microscopy | Turbidity, particle analysis, concentration measurement |
| Relationship | May precede precipitation | May involve aggregated or non-aggregated material |
Why the Distinction Matters
A sample can contain soluble aggregates without visible precipitation.
Conversely, precipitation may occur because of limited equilibrium solubility without requiring a complex aggregation pathway.
Accurate interpretation of peptide aggregation therefore requires attention to the physical state of the material.
Peptide Aggregation vs Chemical Degradation
Chemical degradation involves changes to molecular composition or structure.
Aggregation involves molecular association.
These processes can occur independently or influence one another.
Aggregation Without Chemical Modification
Peptide molecules may associate while retaining their original covalent structures.
Chemical Degradation Without Aggregation
A peptide may undergo oxidation or deamidation without forming detectable aggregates.
Chemical Changes That Promote Aggregation
Some modifications may alter hydrophobicity, charge or conformation.
These changes can influence aggregation propensity.
Aggregation That Affects Chemical Stability
Association may change the accessibility of particular molecular groups.
The resulting effect depends on the system.
Analytical Distinction
HPLC and LC-MS can provide information about chemical composition.
SEC, DLS and other methods may provide information about molecular assemblies.
Read Peptide Oxidation and Degradation.
How Laboratories Detect Peptide Aggregation
Different methods examine different aggregate characteristics.
1. Size-Exclusion Chromatography (SEC)
SEC separates components according to their hydrodynamic behaviour under the method conditions.
It is commonly used to investigate monomeric and higher-molecular-size species.
What SEC Can Show
A suitable SEC method may distinguish some soluble aggregate populations from monomeric material.
Limitations
Aggregates may dissociate, interact with the column or behave differently from ideal size-exclusion assumptions.
SEC does not universally detect every aggregate type.
2. Dynamic Light Scattering (DLS)
DLS measures fluctuations in scattered light associated with particles undergoing Brownian motion.
It can provide information about hydrodynamic size distributions.
What DLS Can Show
DLS may detect larger particles or molecular assemblies in suitable samples.
Limitations
Scattering intensity is strongly influenced by particle size.
A small population of larger particles can dominate the signal.
DLS is not inherently a direct measurement of the mass fraction of each aggregate population.
3. Analytical Ultracentrifugation
Analytical ultracentrifugation examines molecular behaviour under centrifugal force.
It can provide information about sedimentation characteristics and molecular association.
Advantages
It can investigate some solution-state assemblies without requiring chromatographic separation.
Limitations
Interpretation depends on the model, sample properties and experimental design.
4. Fourier-Transform Infrared Spectroscopy
FTIR can provide information about molecular vibrations and certain structural characteristics.
Secondary Structure
Amide-region spectral features may help investigate changes associated with peptide secondary structure.
Limitations
Spectral interpretation can be complex, and overlapping signals may complicate conclusions.
5. Circular Dichroism Spectroscopy
Circular dichroism can provide information about peptide secondary structure under suitable conditions.
Structural Changes
Changes in spectra may indicate alterations in molecular conformation or assembly.
Limitations
CD does not directly provide a complete aggregate size distribution.
6. Electron Microscopy
Electron microscopy can provide images of selected aggregate structures.
Morphology
It may reveal fibrils, particles or other assemblies.
Limitations
Sample preparation and imaging conditions can influence the observed structures.
7. Turbidity and Light Scattering Measurements
Turbidity measurements can detect changes associated with suspended particles.
Advantages
They can provide a relatively simple indication of changes in optical properties.
Limitations
Turbidity does not identify the chemical composition or detailed structure of the particles.
Comparison of Peptide Aggregation Detection Methods
| Method | Main information | Limitation |
|---|---|---|
| SEC | Separation of some soluble aggregate populations | Dilution or column interactions may alter assemblies |
| DLS | Hydrodynamic size information | Large particles can dominate scattering |
| Analytical ultracentrifugation | Sedimentation and association behaviour | Requires specialised interpretation |
| FTIR | Selected structural information | Spectral overlap |
| Circular dichroism | Secondary-structure-related information | Does not directly quantify all aggregates |
| Electron microscopy | Aggregate morphology | Sample preparation can influence observations |
| Turbidity | Optical evidence of suspended particles | Not chemically specific |
A robust peptide aggregation study may combine complementary methods to address different aspects of the sample.
Why HPLC Purity Does Not Establish the Absence of Aggregates
High-performance liquid chromatography is commonly used to assess peptide-related components.
However, a conventional reversed-phase HPLC purity result does not necessarily describe the aggregation state of the original sample.
Chromatographic Conditions Can Change Molecular Association
Organic solvents, mobile-phase conditions and chromatographic interactions may alter aggregate populations.
Soluble Aggregates May Dissociate
Some assemblies may separate into individual peptide molecules under the analytical conditions.
Insoluble Material May Be Excluded
Sample preparation or filtration may remove particles before analysis.
Relative Peak Area Is Not Aggregate Content
A principal peak area percentage does not directly quantify aggregate populations.
Complementary Testing
SEC, DLS or other suitable techniques may be needed to examine physical association.
Peptide aggregation should therefore be evaluated separately from conventional HPLC area purity.
Read HPLC Peptide Purity Testing.
Can LC-MS Detect Peptide Aggregation?
Mass spectrometry can provide molecular information about peptide species.
However, routine LC-MS does not automatically preserve or characterise the aggregation state present in the original solution.
Molecular-Mass Evidence
LC-MS can identify certain chemical components through their molecular masses.
Chemical Modifications
It can help investigate modifications that may influence aggregation.
Native Mass Spectrometry
Specialised native mass spectrometry may preserve some noncovalent assemblies under suitable conditions.
Method Dependence
Ionisation and chromatographic conditions can disrupt molecular associations.
Interpretation
Routine LC-MS evidence should not be treated as a complete measurement of aggregate populations.
Read LC-MS Peptide Analysis.
Peptide Aggregation and Solubility
Aggregation and solubility influence one another but describe different properties.
Molecularly Dissolved Peptides
Individual peptide molecules may remain in solution.
Soluble Aggregates
Associated peptide molecules may also remain dispersed.
Insoluble Aggregates
Larger assemblies may separate from solution.
Apparent Solubility
A preparation may appear fully dissolved without containing exclusively monomeric peptide.
Equilibrium Behaviour
Aggregation can influence the distribution of peptide species under particular conditions.
Analytical Implications
A solubility measurement should define what is being quantified.
Read Peptide Solubility.
Peptide Aggregation in Lyophilised Materials
Lyophilised peptides are freeze-dried preparations containing reduced amounts of water.
Aggregation-related behaviour can be relevant to both solid-state and solution-state studies.
Solid-State Molecular Interactions
Peptides may interact within a dried matrix.
Residual Moisture
Water content can influence molecular mobility and physical properties.
Formulation Composition
Additional constituents may affect physical stability.
Rehydration Behaviour in Analytical Studies
The aggregate population observed after a dried material is brought into solution may depend on the original material and the conditions used.
Chemical vs Physical Stability
A material may retain its molecular identity while exhibiting altered physical behaviour.
Evidence Requirements
Lyophilisation does not automatically establish that a peptide is free from aggregates.
Read Lyophilised Peptide Stability.
Peptide Aggregation and Storage Stability
Aggregation may develop during storage under particular conditions.
Time-Dependent Association
Some systems exhibit gradual changes in aggregate populations.
Temperature Effects
Temperature can influence aggregation kinetics and equilibria.
Packaging Effects
Container surfaces and interfaces may affect certain preparations.
Chemical Modifications
Storage-related degradation may alter molecular interactions.
Physical Changes
Aggregation may occur without detectable covalent modification.
Stability Studies
A suitable study should examine relevant physical and chemical characteristics over time.
Peptide aggregation is therefore an important consideration when evaluating the physical stability of certain research peptide preparations.
Read Peptide Stability Testing.
Example of a Hypothetical Peptide Aggregation Study
Consider a fictional peptide solution examined over several weeks.
A laboratory uses a suitable analytical method to estimate the relative proportions of monomeric and higher-molecular-size species.
| Time point | Monomer-associated signal | Higher-molecular-size signal |
|---|---|---|
| Initial | 98.5% | 1.5% |
| Week 1 | 97.8% | 2.2% |
| Week 2 | 96.4% | 3.6% |
| Week 4 | 94.7% | 5.3% |
These values are hypothetical and do not represent verified commercial batch data.
They illustrate how the relative analytical profile might change over time.
However, the figures do not independently establish absolute aggregate mass fractions.
The interpretation would depend on the analytical method, response characteristics, sample preparation and measurement uncertainty.
A complete peptide aggregation study should also consider whether the detected assemblies are reversible, chemically modified or associated with other physical changes.
How Peptide Aggregation Affects Laboratory Reproducibility
Aggregation can influence the distribution of peptide species within a preparation.
Monomer Concentration
The concentration of individual peptide molecules may differ from the nominal total concentration.
Aggregate Distribution
Different samples may contain different proportions of assemblies.
Surface Interactions
Peptides and aggregates may interact with laboratory materials.
Time Dependence
Aggregate populations may change during an experiment.
Analytical Interference
Aggregates may influence measurements in ways that depend on the technique.
Batch Differences
Different material batches may exhibit different physical behaviour.
Documentation
Recording relevant conditions helps researchers interpret findings.
A scientifically responsible peptide aggregation assessment should distinguish observed analytical results from assumptions about the underlying mechanism.
Peptide Aggregation and Certificates of Analysis
A certificate of analysis may report identity, purity, content or other selected quality characteristics.
However, a standard peptide COA does not necessarily include aggregation testing.
Identity Results
Mass spectrometry may support molecular identity.
Purity Results
HPLC may describe relative chromatographic composition.
Aggregate Testing
SEC, DLS or other methods may provide information about physical assemblies.
Stability Testing
Longitudinal studies may examine changes in aggregate populations.
Batch Traceability
The results should correspond to an identifiable material.
Reporting Limitations
A COA should not be interpreted as establishing the absence of aggregation unless suitable evidence is provided.
Read Peptide Certificate of Analysis.
Common Misconceptions About Peptide Aggregation
Misconception 1: All Aggregates Are Visible
Small soluble aggregates may not produce visible changes.
Misconception 2: Aggregation Always Means Chemical Degradation
Molecular association can occur without changes to covalent structure.
Misconception 3: A Clear Solution Contains Only Monomers
Soluble assemblies may remain present.
Misconception 4: High HPLC Purity Proves the Absence of Aggregates
Conventional chromatographic purity measurements do not necessarily characterise the original aggregation state.
Misconception 5: Every Peptide Forms Amyloid Fibrils
Fibril formation is sequence- and condition-dependent.
Misconception 6: Aggregation Is Always Irreversible
Some molecular associations are reversible.
Misconception 7: DLS Directly Measures Aggregate Mass Percentage
DLS is strongly influenced by particle size and scattering intensity.
Misconception 8: A COA Automatically Includes Aggregation Testing
Aggregation testing must be specifically supported by suitable analytical evidence.
Understanding these distinctions improves the interpretation of peptide aggregation findings.
How Laboratories Design Peptide Aggregation Studies
A useful study begins with a clearly defined analytical objective.
Define the Peptide Material
The peptide sequence, modifications and physical form should be identified.
Define the Solution Environment
Relevant conditions may include pH, ionic strength, solvent composition and temperature.
Establish the Concentration Range
Concentration can influence association equilibria and kinetics.
Select Complementary Methods
Different methods may be needed to examine size, morphology and molecular structure.
Consider Sample Preparation Effects
Analytical preparation can change aggregate populations.
Establish Measurement Time Points
Time-dependent behaviour may require repeated observations.
Evaluate Method Limitations
Each technique has detection limits and potential sources of bias.
Document Findings
Conclusions should be supported by the actual data.
Reliable peptide aggregation studies distinguish between direct measurements, calculated estimates and proposed mechanisms.
Frequently Asked Questions About Peptide Aggregation
1. What is peptide aggregation?
Peptide aggregation is the association of peptide molecules into larger assemblies, which may remain soluble or form insoluble particles.
2. What causes peptide aggregation?
Amino acid sequence, concentration, pH, temperature, ionic strength, solvent composition and environmental exposure can influence aggregation.
3. Can peptides aggregate without visible precipitation?
Yes. Soluble oligomers and other assemblies may be present in visually clear preparations.
4. Is peptide aggregation the same as chemical degradation?
No. Aggregation involves molecular association, while chemical degradation involves changes to molecular composition or structure.
5. How do laboratories detect peptide aggregation?
Methods may include size-exclusion chromatography, dynamic light scattering, analytical ultracentrifugation, spectroscopy and microscopy.
6. Can HPLC purity testing detect all peptide aggregates?
No. Conventional reversed-phase HPLC purity analysis does not necessarily preserve or measure the original aggregation state.
7. Does lyophilisation prevent peptide aggregation?
Not universally. Freeze-drying can influence physical stability, but aggregation behaviour depends on the peptide and formulation.
8. Can peptide aggregation affect research results?
Yes. Aggregation can influence dissolved monomer concentration, sample behaviour and certain analytical measurements, potentially affecting reproducibility.
Conclusion: Understanding Peptide Aggregation
Peptide aggregation is a complex physicochemical process involving the association of peptide molecules into larger assemblies.
Its behaviour depends on amino acid sequence, concentration, pH, temperature, ionic strength, solvent composition and environmental exposure.
Some aggregates remain soluble, while others form particles or precipitates. Certain peptide systems may also produce ordered fibrillar structures.
However, aggregation should not automatically be equated with chemical degradation, irreversible instability or visible precipitation.
Size-exclusion chromatography, dynamic light scattering, analytical ultracentrifugation, spectroscopy and microscopy provide complementary information about aggregate populations.
The choice of method depends on the peptide and the analytical question.
Reliable peptide aggregation assessment requires defined experimental conditions, appropriate methods and careful interpretation of the evidence.
For synthetic peptide researchers, distinguishing molecular association from chemical degradation and limited solubility is essential to understanding physical stability and laboratory reproducibility.
Scientific References and Further Reading
- Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., Katayama, D. S. (2010). Stability of Protein Pharmaceuticals: An Update. Pharmaceutical Research, 27, 544–575.
https://doi.org/10.1007/s11095-009-0045-6 - Wang, W. (1999). Instability, Stabilization, and Formulation of Liquid Protein Pharmaceuticals. International Journal of Pharmaceutics, 185(2), 129–188.
https://doi.org/10.1016/S0378-5173(99)00152-0 - Dobson, C. M. (2003). Protein Folding and Misfolding. Nature, 426, 884–890.
https://doi.org/10.1038/nature02261 - Knowles, T. P. J., Vendruscolo, M., Dobson, C. M. (2014). The Amyloid State and Its Association with Protein Misfolding Diseases. Nature Reviews Molecular Cell Biology, 15, 384–396.
https://doi.org/10.1038/nrm3810 - International Council for Harmonisation (ICH). Q2(R2): Validation of Analytical Procedures.
https://www.ich.org/page/quality-guidelines - International Council for Harmonisation (ICH). Q14: Analytical Procedure Development.
https://www.ich.org/page/quality-guidelines - United States Pharmacopeia (USP). Analytical standards and quality resources.
https://www.usp.org/
The protein aggregation literature provides relevant physicochemical principles, but individual findings should not be assumed to apply identically to every short synthetic peptide.
Research information notice: This article is intended for laboratory education and analytical research. It does not establish the aggregation state, purity, stability or suitability for human or veterinary administration of any particular commercial peptide batch.